产品名称
抗-NeuN抗体, from chicken, purified by affinity chromatography
biological source
chicken
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
purified by
affinity chromatography
species reactivity
mouse, rat
technique(s)
immunocytochemistry: suitable
immunohistochemistry: suitable (paraffin)
western blot: suitable
isotype
IgY
shipped in
wet ice
target post-translational modification
unmodified
Gene Information
mouse ... Rbfox3(52897)
rat ... Rbfox3(287847)
Analysis Note
对照
小鼠脑E16组织裂解物
小鼠脑E16组织裂解物
通过蛋白质印迹在小鼠脑E16组织裂解物中进行了评估。
蛋白质印迹分析：0.5 µg/mL该抗体在10 µg小鼠脑E16组织裂解物中检测到NeuN。
蛋白质印迹分析：0.5 µg/mL该抗体在10 µg小鼠脑E16组织裂解物中检测到NeuN。
Application
免疫细胞化学分析： 代表性批次的1：500稀释液在大鼠E18皮质细胞中检测到NeuN。
免疫组化分析： 代表性批次的1：500稀释液在小鼠大脑，小鼠海马和小鼠额叶皮层组织中检测到NeuN。
免疫组化分析： 代表性批次的1：500稀释液在小鼠大脑，小鼠海马和小鼠额叶皮层组织中检测到NeuN。
研究子类别
发育神经科学
发育神经科学
研究类别
神经科学
神经科学
该抗NeuN抗体经验证可用于IHC（P）、蛋白质印迹和ICC检测NeuN。
Biochem/physiol Actions
其他同源性： 人（94%序列同源性）。
该抗体识别NeuN的N末端。
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
General description
NeuN（RNA结合蛋白fox-1同源物3；Fox-1同源物C）是仅在神经元细胞核中发现的RNA结合蛋白。它是进化上保守的Fox-1家族的成员，主要参与RNA的剪接。
观察值〜45 kDa。 在某些裂解物中，未表征的条带出现在〜40和〜50 kDa处。
Immunogen
GST标记的重组蛋白，对应于小鼠NeuN的N末端。
表位：N末端
Other Notes
Physical form
亲和纯化
在含 0.1 M Tris-甘氨酸（pH 7.4），150 mM NaCl和0.05％叠氮化钠的缓冲液中的纯化的鸡多克隆抗体。
Preparation Note
自收到之日起，在 2-8°C 条件下可稳定保存1年
未找到合适的产品？
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Zsofia I Kovacs et al.
Theranostics, 8(17), 4837-4855 (2018-10-04)
Magnetic resonance imaging (MRI)-guided pulsed focused ultrasound (pFUS) combined with microbubbles (MB) contrast agent infusion has been shown to transiently disrupt the blood-brain barrier (BBBD), increasing the delivery of neurotherapeutics to treat central nervous system (CNS) diseases. pFUS interaction with
Luiz Alexandre Viana Magno et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 39(17), 3234-3248 (2019-02-21)
Neuromodulation of deep brain structures (deep brain stimulation) is the current surgical procedure for treatment of Parkinson's disease (PD). Less studied is the stimulation of cortical motor areas to treat PD symptoms, although also known to alleviate motor disturbances in
Mariana Bravo-Hernández et al.
Pain, 157(3), 613-626 (2015-11-07)
It has been recently proposed that α5-subunit containing GABAA receptors (α5-GABAA receptors) that mediate tonic inhibition might be involved in pain. The purpose of this study was to investigate the contribution of α5-GABAA receptors in the loss of GABAergic inhibition
Alexander J Davies et al.
Cell, 176(4), 716-728 (2019-02-05)
Sensory axons degenerate following separation from their cell body, but partial injury to peripheral nerves may leave the integrity of damaged axons preserved. We show that an endogenous ligand for the natural killer (NK) cell receptor NKG2D, Retinoic Acid Early 1
Curt Mazur et al.
JCI insight, 4(20) (2019-10-18)
Intrathecal (IT) delivery and pharmacology of antisense oligonucleotides (ASOs) for the CNS have been successfully developed to treat spinal muscular atrophy. However, ASO pharmacokinetic (PK) and pharmacodynamic (PD) properties remain poorly understood in the IT compartment. We applied multimodal imaging
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持